Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quetiapine or haloperidol as monotherapy for bipolar mania—a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

Published:2005-10 Issue:5 Volume:15 Page:573-585
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

McIntyre Roger S.,Brecher Martin,Paulsson Björn,Huizar Karin,Mullen Jamie

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference43 articles.

1. Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study;Altamura;J. Affect Disord.,2003

2. Practice guideline for the treatment of patients with bipolar disorder;Am. J. Psychiatry,2002

3. Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group;Arvanitis;Biol. Psychiatry,1997

4. A rating scale for drug-induced akathisia;Barnes;Br. J. Psychiatry,1989

5. Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia;Buckley;Schizophr. Res.,2004

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medications for Bipolar Disorder;Tasman’s Psychiatry;2024

2. Non-interventional epidemiological program for investigating the real-life practice of using quetiapine (Seroquel®) in patients with schizophrenia and bipolar affective disorder (EPIDEMICUS);Neurology, Neuropsychiatry, Psychosomatics;2023-12-16

3. Medications for Bipolar Disorder;Tasman’s Psychiatry;2023

4. A Brief Review of Quetiapine;American Journal of Psychiatry Residents' Journal;2022-12-02

5. Psychopharmacological Recovery-Oriented Treatments in Bipolar Disorders;Recovery and Major Mental Disorders;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3